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SOCIETY NEWS
Congress 110
…That is, the 110th Congress, not a course called Congress 110.
As you know, there has been a major shift in the Congress, as
the Democrats now have control of both houses for the first time
in a dozen years. The House, with new speaker Nancy Pelosi (D-
CA), wasted little time in passing several pieces of legislation in
the first 100 hours of the House session, including a bill (HR 3)
to lift restrictions on federal funding of stem cell research. A
bill will then have to be passed by the Senate and sent to con-
ference if the language differs from that of the House bill. This
was accomplished in the last Congress, but then the bill was sent
to the President, and the first veto of the Bush administration
was administered. There has been no substantial change in the
position of the President on this issue since that time.
In the initial hours of this Congress, focus turned to federal
spending as well. The 109th Congress failed to pass 10 of 12
fiscal year 2007 (FY2007) appropriations bills and, in place of
those bills, passed a continuing resolution that was in place
through February 15, 2007, for agencies whose spending bills
have not been enacted. Democrats have stated that their inten-
tion is to keep the budget under control and specifically that they
plan to extend FY2006 funding levels until the end of FY2007
(i.e., September 30, 2007). Maintaining the FY2006 funding level
would at least mean that the proposed FY2007 cuts in the Pres-
idential budget would not be imposed. Some adjustments may
be made to programs that maintain high policy priority, and, to
that end, members of ASHG and the Federation of American So-
cieties for Experimental Biology (FASEB) have sent Congressional
leadership and policy alerts to urge their elected officials (two
Senators and one Representative each) to remind the leadership
that the National Institutes of Health and the funding of scientific
research are indeed high priorities for the health and well-being
of the country. We will remain vigilant on these funding issues
and will, from time to time, send e-mail messages to ask the ASHG
membership to contact their elected officials. We try to be stra-
tegic and timely in these requests, asking for responses when the
issue is on the agenda of major discussions on Capitol Hill.
The Genetic Information Non-Discrimination Act (GINA)
is also back on the agenda of the new Congress, with the bill
introduced in the House (HR 493) and the Senate (S 358) in the
latter part of January. ASHG remains active in the Coalition for
Genetic Fairness, the group focused on the passage of this latest
version of the bill. The identical wording was introduced in both
houses and reflects the version most recently passed unanimously
by the Senate in 2006. The appropriate committees in the two
houses will mark up the bill, and then it will go to the floor in
each chamber for a vote. The White House remains supportive
of these bills, and if a bill gets sent to the President, it should be
signed fairly quickly. The passage of this legislation remains a
policy priority for ASHG, because lack of appropriate protection
of genetic information has been demonstrated to deter partici-
pation in research, as well as to prevent some individuals and
families from pursuing testing for genetic predisposition to dis-
ease. By the time of this publication, additional actions will have
been requested of ASHG members, and, hopefully, Congressional
actions will have been completed! ASHG will have links from our
home page (http://www.ashg.org/) to regular updates on the pro-
gress of the legislation.
The membership of key committees dealing with issues of
keen interest to our membership may be found on the FASEB
Web site (http://opa.faseb.org/pages/WashingtonUpdate/). These
members of Congress will be especially important to contact, but
it is also critical that all members and their staffers be aware of
the activities in their home districts. We continue to encourage
scientists to invite their elected officials to their labs to see the
important work and advances being made through the efficient
use of federal resources. When inviting an elected official to visit,
it is important to contact your university officials (i.e., the Gov-
ernment Affairs office) to inform them, so that they may assist
you in the planning of the visit.
International Issues
Although much of our energy is focused on the actions of the
U.S. Congress, primarily because the funding issue is so critical
to thousands of our ASHG members, we are keenly aware that
many of the issues facing research are global in nature. We
continue to follow the leadership of other nations and interna-
tional scientific organizations in issues such as stem cell research
policies.
In the past few years, we have worked with colleagues and the
State Department to streamline the documentation process for
students and postdoctoral fellows coming into the United States.
ASHG continues to seek input from our international members
regarding issues of importance to them.
If you have ideas or suggestions, please do not hesitate to con-
tact me at jboughman@ashg.org.
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